VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
批准号:
6628085
负责人:
Peter C. Melby
金额:
$31.15万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-02-01 至 2004-01-31
关键词:
Leishmania Psychodidae active immunization arthropod borne communicable disease biotechnology cellular immunity combination chemotherapy communicable disease control communicable disease transmission cytokine disease vectors dogs drug administration routes enzyme linked immunosorbent assay humoral immunity immunocytochemistry immunomodulators immunotherapy leishmaniasis nonhuman therapy evaluation protozoal vaccine serial analysis of gene expression vaccine development vector vaccine zoonosis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Visceral leishmaniaisis (VL), caused by Leishmania chagasi in the New World, is a zoonotic disease in which the domestic dog is the principal reservoir host in the peridomestic setting. The sand fly Lutzomyia longipalpis is the principal vector. This proposal is focused on vaccination against canine visceral leishmaniasis with the goal of decreasing the reservoir's infectivity to the sand fly vector, and thus interrupting transmission of this parasite to humans. We hypothesize that even partial protection of dogs will significantly impact the ability of this host to infect the sand fly vector and maintain the transmission of L. chagasi. These proposed studies are an extension of previous work in which we have i) defined the rate of enzootic transmission of L. chagasi within an endemic area, ii) characterized the relationship between the clinical and parasitological status of L. chagasi infected dogs and their infectivity to sand flies, iii) identified a multi-component DNA vaccine that induces a protective immune response in a murine model of VL, and iv) developed canine cytokine DNA constructs for use as vaccine adjuvants. We will determine the optimal route of vaccine delivery of the DNA vaccine and if co-delivery of cytokine DNA can have an adjuvant effect in the canine vaccine model. The protective efficacy of the multi- component vaccine will be tested in parallel by: i) experimental challenge of immunized and control dogs with Lu. longipalpis-derived metacyclic promastigotes, and ii) natural challenge by exposure to naturally infected Lu. longipalpis in an endemic area. The primary efficacy endpoint will be a reduction in the infectivity of the vaccinated dogs to laboratory-reared sand flies. The secondary endpoints for vaccine efficacy will be a reduction in clinical disease and parasite burden in the vaccinated compared to unvaccinated dogs. Successful vaccination of dogs in an endemic could reduce both enzootic (among the canine reservoir) and zoonotic (from the canine reservoir to humans) transmission.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Quantification of canine cytokines using real time reverse transcriptase polymerase chain reaction.
使用实时逆转录酶聚合酶链反应定量犬细胞因子。
DOI:
--
发表时间:
2006
期刊:
Biomedica : revista del Instituto Nacional de Salud
影响因子:
--
作者:
[Saldarriaga,OmarA, Travi,BrunoL, Melby,PeterC]
通讯作者:
Melby,PeterC
Clinical, parasitologic, and immunologic evolution in dogs experimentally infected with sand fly-derived Leishmania chagasi promastigotes.
实验性感染白蛉利什曼原虫前鞭毛体的狗的临床、寄生虫学和免疫学进化。
DOI:
10.4269/ajtmh.2009.09-0229
发表时间:
2009
期刊:
The American journal of tropical medicine and hygiene
影响因子:
--
作者:
[Travi,BrunoL, Osorio,ElviaYaneth, Saldarriaga,OmarA, Cadena,Horacio, Tabares,CarlosJavier, Peniche,Alex, Lee,Shuko, Melby,PeterC]
通讯作者:
Melby,PeterC
Vaccination against cutaneous leishmaniasis: current status.
皮肤利什曼病疫苗接种:现状。
DOI:
10.2165/00128071-200203080-00006
发表时间:
2002
期刊:
American journal of clinical dermatology
影响因子:
7.3
作者:
[Melby,PeterC]
通讯作者:
Melby,PeterC
Immunogenicity of a multicomponent DNA vaccine against visceral leishmaniasis in dogs.
多组分 DNA 疫苗针对犬内脏利什曼病的免疫原性。
DOI:
10.1016/j.vaccine.2005.10.052
发表时间:
2006
期刊:
Vaccine.
影响因子:
--
作者:
[Saldarriaga,OmarA, Travi,BrunoL, Park,Won, Perez,LuisE, Melby,PeterC]
通讯作者:
Melby,PeterC
Selective enhancement of the type 1 cytokine response by expression of a canine interleukin (IL)-12 fused heterodimeric DNA.
通过表达犬白细胞介素 (IL)-12 融合异二聚体 DNA 选择性增强 1 型细胞因子反应。
DOI:
10.1016/j.vetimm.2005.11.003
发表时间:
2006
期刊:
Veterinary immunology and immunopathology.
影响因子:
--
作者:
[Saldarriaga,OmarA, Perez,LuisE, Travi,BrunoL, Melby,PeterC]
通讯作者:
Melby,PeterC
Physician-Scientist Training in Emerging Infectious Diseases
-
批准号:10647762
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2021
-
负责人:Peter C. Melby
-
依托单位:
Physician-Scientist Training in Emerging Infectious Diseases
-
批准号:10270872
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2021
-
负责人:Peter C. Melby
-
依托单位:
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis
-
批准号:10062846
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2017
-
负责人:Peter C. Melby
-
依托单位:
Mechanisms of Parasite Dissemination in Visceral Leishmaniasis
-
批准号:10302274
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2017
-
负责人:Peter C. Melby
-
依托单位:
Malnutrition-related Lymph Node Dysfunction and Risk of Visceral Leishmaniasis
-
批准号:8702843
-
项目类别:
-
资助金额:$23.24万
-
财政年份:2014
-
负责人:Peter C. Melby
-
依托单位:
Discovery of 4-aminoquinoline therapeutics for visceral leishmaniasis
-
批准号:8207443
-
项目类别:
-
资助金额:$49.98万
-
财政年份:2010
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
-
批准号:7758284
-
项目类别:
-
资助金额:$3.38万
-
财政年份:2009
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
-
批准号:7559198
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2009
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis-FIRCA supplement
-
批准号:8012292
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2009
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7347521
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7009285
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7174817
-
项目类别:
-
资助金额:$29.51万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:6922649
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
NOS2 and arginase in visceral leishmaniasis
-
批准号:7577390
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2005
-
负责人:Peter C. Melby
-
依托单位:
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
-
批准号:6258034
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2001
-
负责人:Peter C. Melby
-
依托单位:
VACCINATION OF DOGS TO REDUCE TRANSMISSION OF LEISHMANIA
-
批准号:6497391
-
项目类别:
-
资助金额:$31.31万
-
财政年份:2001
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6464011
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6529843
-
项目类别:
-
资助金额:$24.21万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6612888
-
项目类别:
-
资助金额:$18.83万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
MOLECULAR TOOLS TO DEVELOP HAMSTER MODELS OF DISEASE
-
批准号:6129514
-
项目类别:
-
资助金额:$19.33万
-
财政年份:2000
-
负责人:Peter C. Melby
-
依托单位:
海外基金